1. ？Chen F X, Gao X S. Huanglian single prescriptions and Huanglian therapy. Chinese Traditional Patent Medicine, 1997b(19): 36-37.
[2]
2. Hano K. The carcinostatic effects of some plant components and their related compounds. Acta Unio Int Contra Cancrum, 1959, 15(Suppl 1): 122.
[3]
3. Tang J, Feng Y, Tsao S, et al. Berberine and coptidis rhizoma as novel antineoplastic agents: a review of traditional use and biomedical investigations. J Ethnopharmacol, 2009, 126(1): 5-17.
[4]
4. Sun Y, Xun K, Wang Y, et al. A systematic review of the anticancer properties of berberine, a natural product from Chinese herbs. Anticancer Drugs, 2009, 20(9): 757-769.
[5]
5. Tillhon M, Guamán Ortiz L M, Lombardi P, et al. Berberine: new perspectives for old remedies. Biochem Pharmacol, 2012, 84(10): 1260-1267.
[6]
6. Zhang Xiaoling, Gu Lubing, Li Jiansha, et al. Degradation of MDM2 by the interaction between berberine and DAXX leads to potent apoptosis in MDM2-overexpressing cancer cells. Cancer Res, 2010, 70(23): 9895-9904.
[7]
7. Liu Q, Jiang H, Liu Z, et al. Berberine Radio sensitizes human esophageal cancer cells by downregulating homologous recombination repair protein RAD51. PLoS One, 2011(6): e23427.
[8]
8. Li J, Gu L, Zhang H, et al. Berberine represses DAXX gene transcription and induces cancer cell apoptosis. Lab Invest, 2013, 93(3): 354-364.
[9]
9. Mei X L, Wu X A, Fan C Z, et al. Radiosynthesis of novel18F-berberine derivatives as potential tumor imaging agent//The 59th Society of Nuclear Medicine Annual Meeting, Miami Beach, Florida: 2012, 53 (Supplement 1):1680.
11. LIU Bing, WANG Genshu, YANG Jie, et al. Berberine inhibits human hepatoma cell invasion without cytotoxicity in healthy hepatocytes. PLoS One, 2011, 6(6): e21416.
[12]
12. Long N M, Smith C S. Causes and imaging features of false positives and false negatives on F-PET/CT in oncologic imaging. Insights Imaging, 2011, 2(6): 679-698.
[13]
13. Yin J, Xing H, Ye J. Efficacy of berberine in patients with type 2 diabetes mellitus. Metabolism, 2008, 57(5): 712-717.
[14]
14. WEI Wei, ZHAO Hongmin, WANG Aili, et al. A clinical study on the short-term effect of berberine in comparison to metformin on the metabolic characteristics of women with polycystic ovary syndrome. Eur J Endocrinol, 2012, 166(1): 99-105.
[15]
15. Pereira G C, Branco A F, Matos J A, et al. Mitochondrially targeted effects of berberine [Natural Yellow 18, 5, 6-dihydro-9, 10-dimethoxybenzo(g)-1, 3-benzodioxolo(5, 6-a) quinolizinium] on K1735-M2 mouse melanoma cells: comparison with direct effects on isolated mitochondrial fractions. J Pharmacol Exp Ther, 2007, 323(2): 636-649.
[16]
16. Serafim T L, Oliveira P J, Sardao V A, et al. Different concentrations of berberine result in distinct cellular localization patterns and cell cycle effects in a melanoma cell line. cancer Chemother Pharmacol, 2008, 61(6): 1007-1018.
[17]
17. Singh I P, Mahajan S. Berberine and its derivatives:a patent review (2009-2012). Expert Opin Ther Pat, 2013, 23(2): 215-231.
[18]
18. Diogo C V, Machado N G, Barbosa I A, et al. Berberine as a promising safe anti-cancer agent-is there a role for mitochondria? Curr Drug Targets, 2011, 12(6): 850-859.
